Free and bound choline blood levels after phosphatidylcholine by Jope, Richard S et al.
Free and bound choline blood levels after phosphatidylcholine 
In six normal subjects we investigated the effects of oral phosphatidylcholine (lecithin) on the 
concentrations of plasma choline, erythrocyte choline, and choline-containing lipids. Plasma 
choline levels rose I hr after treatment and remained elevated for 8 hr, with peaks at 3 and 4 hr 
after phosphatidylcholine. Erythrocyte choline levels also rose, although the rise was slightly 
delayed relative to plasma choline. There was no change in the plasma choline-containing lipid 
concentration. These results demonstrate that, in normal subjects, oral phosphatidylcholine 
induces prolonged rises in plasma and erythrocyte choline concentrations and is therefore useful 
when such effects are desired. 
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Clinical and laboratory research in the field of 
central nervous system cholinergic pharmacol- 
ogy has been seriously hampered by the lack 
of a long-lasting cholinomimetic agent that is 
active in the brain. Based on the contention that 
increased levels of choline will increase the 
concentration of choline in the brain since the 
choline transport system across the blood brain 
barrier (KT approximately 440 ktM) is not satu- 
rated by the normal plasma choline concentra- 
tion of 10 to 20 ,uM,6 Haubrich et al.") and 
Wurtman et a1.5' 20 suggested the use of large 
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doses of choline to promote acetylcholine 
(ACh) synthesis. Systemic administration of 
choline may lead to a rise in choline levels in 
the brain,5' 10 but a resultant elevation in levels 
and utilization of ACh is controversial (for re- 
view, see Jenden"). 
Recently choline has been partially super- 
seded by the use of phosphatidylcholine* (PCh), 
which does not give rise to the strong "fishy" 
odor obtained after choline treatment .4' " PCh 
has been reported to be beneficial in patients 
with tardive dyskinesia8' 22 and is undergoing 
clinical evaluation in a number of other dis- 
eases.2-4, 7, 18, 19 Since the clinical use of the 
*Although the term lecithin has recently been used in reports of 
investigations of phosphatidylcholine therapy, lecithin has long been 
used to indicate an impure mixture of phosphatides. We therefore 
use phosphatidyl to more accurately identify the compound under 
investigation. 
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Fig. 1. A, Plasma choline concentration. B, Average percent changes in plasma choline (o), plasma 
lipid bound choline (o), and erythrocyte choline (e) obtained from six normal subjects after oral PCh 
(15 gm/70 kg body weight). The initial plasma choline, erythrocyte choline, and plasma lipid bound 
choline concentrations were 7.4 ± 2.0, 15.3 ± 4.9, and 996 ± 234 (T( -± SD). 
drug is expanding rapidly, we studied the PCh 
kinetics in six normal subjects. Wurtman et al.21 
and Hirsch et al.12 reported that human con- 
sumption of a meal supplemented with 100 gm 
of impure PCh granules (equivalent to 2.3 gm 
choline) increased serum choline concentration. 
This effect was reported to last for at least 12 hr, 
at which time serum choline was at its highest 
leve1.12 21 More recently Zeisel et al.23 reported 
that 25 gm of 80% pure PCh quadrupled plasma 
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choline concentration with a peak level at ap- 
proximately 5 hr after treatment. We report here 
the effects of PCh consumption by normal sub- 
jects on plasma choline, erythrocyte choline, 
and choline-containing lipids in the plasma. 
Since this pool may also be a precursor of brain 
choline and ACh,l' 15 choline-containing lipids 
were measured to determine whether consump- 
tion of a large amount of PCh altered the release 
of lipid bound choline into the blood. Eryth- 
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rocyte choline was measured as an index of 
changes of the choline concentration in an intra- 
cellular pool, and also because it has been shown 
to rise after lithium'6 and in some patients with 
affective disorders .9' 16 
Materials and methods 
Six subjects were studied. Each took 15 
gm/70 kg body weight (total dose = 11.1 to 
16.7 gm PCh) Phospholipon-100 (approxi- 
mately 94% PCh; American Lecithin) at 8:00 to 
9:00 A.M. after an overnight fast. The PCh was 
suspended in 0.45% NaC1 and consumption was 
followed by a small amount of milk. After the 
2-hr blood sample the subjects ate a breakfast of 
orange juice, coffee or tea, and two slices of 
toast with jam and a pat of butter. After the 4-hr 
blood sample was drawn the subjects ate a lunch 
with low PCh content. 
At the indicated times blood was drawn into a 
heparinized syringe and centrifuged at 4° at 
3000 g for 5 mm. Choline in the plasma and 
erythrocytes was extracted in 15% 1N for- 
mic acid in acetone (v/v) that contained pre- 
cisely known quantities of [2H9]-choline as in- 
ternal standard. Choline-containing lipids in the 
plasma were extracted in 20 vol CHC13: Me0H 
(2: 1) containing [2H9]-PCh as internal standard. 
[2H9]-PCh was labeled in the choline moiety by 
predeuteration of the methyl groups. Free cho- 
line was hydrolyzed from the lipids by incuba- 
tion in 1N KOH for 1 hr at 95°. Choline was 
isolated by ion-pair extraction with dipicryl- 
amine into dichloromethane and measured by 
gas chromatographymass spectrometry as pre- 
viously described." Choline was also measured 
by gas chromatography using a nitrogen detector 
with homocholine (3-hydroxypropyltrimethyl- 
ammonium iodide) as the internal standard after 
extraction as described by Kosh et al.17 The 
results of the two assays were almost identical 
with correlation coefficients of 0.98 for choline 
in both plasma and erythrocytes. 
Results 
Oral doses of 15 gm PCh/70 kg body weight 
increased plasma choline concentrations to 
levels three to four times those before treatment 
(Fig. 1, A). Increased concentrations were 
apparent 1 hr after treatment in all subjects. 
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Fig. 2. Average ratios of erythrocyte choline to 
plasma choline in six subjects after oral administra- 
tion of PCh (15 gm/70 kg body weight). 
Plasma choline levels peaked between 3 and 4 
hr after PCh. The duration of the peak plasma 
choline level varied among the subjects, e.g., in 
two subjects there was a well-defined peak 
while in two others there was a plateau between 
3 and 8 hr after treatment. Plasma choline con- 
centrations were near normal, although still 
slightly elevated, 24 hr after treatment. 
Erythrocyte choline concentrations rose in 
approximate parallel to the rise in plasma 
choline (Fig. 1, B), but the increase of choline 
in erythrocytes was delayed relative to the 
plasma choline and reached maximum concen- 
trations between 4 and 6 hr after PCh. The re- 
sults from one subject were omitted from the 
calculations because his initial erythrocyte cho- 
line concentration was 170 ktM, approximately 
10 times that of the other subjects. The high 
erythrocyte choline level was confirmed in a 
repeat determination 1 mo later. The cause of 
this abnormally high level is under investigation. 
The ratio of the choline concentration in 
erythrocytes to that in plasma is shown in Fig. 
2. This indicates that, although the intracellular 
erythrocyte choline concentration rose, it did 
not do so to the same extent as plasma choline. 
Lipid bound choline in the plasma did not 
change after PCh (Fig. 1, B). 
Discussion 
These results demonstrate that, in man, PCh 
raises plasma choline concentration for a longer 
period than an equimolar dose of choline. The 
only side effect noted was mild nausea in two 
subjects approximately 6 hr after treatment. The 
extended effect of, and minimal side effects at- 
tributed to, PCh suggest that it is clinically 
preferable to choline as a means of elevating 
plasma choline levels. 
The only cell easily accessible for measuring 
intracellular choline concentration in man is the 
erythrocyte. PCh induced prolonged elevation 
of erythrocyte choline concentration to much 
the same extent as plasma choline. This is pre- 
sumably a direct result of the increased plasma 
choline concentration since the erythrocyte has 
a transport system with a relatively low affinity 
for choline (40 AM) that is not saturated by the 
normal plasma choline concentration of approx- 
imately 10 M. These results in erythrocytes 
indicate that at least one intracellular pool of 
choline increases after PCh. As shown in Fig. 
2, however, the intracellular erythrocyte choline 
concentration did not rise to the same degree as 
plasma choline. The ratio of erythrocyte choline 
to the plasma choline level may be a useful 
index for monitoring intracellular choline 
changes after PCh or choline. The blood brain 
barrier also has a low affinity for choline (KT = 
440 iuM) so that choline transport from the 
plasma into the brain should also be increased 
by PCh treatment.6 Whether or not increased 
brain choline will alter the activity of choliner- 
gic neurons remains to be determined. Although 
this hypothesis remains unresolved, choline 
loading may have a greater effect in pathologic 
states where there is evidence of cholinergic 
hypofunction. The beneficial effects of PCh 
therapy reported4 and the prolonged increase in 
choline levels, with minimal side effects, fol- 
lowing PCh suggest that it is a drug of choice 
for promoting cholinergic function by precursor 
loading. 
We would like to acknowledge the excellent tech- 
nical assistance of Franz Fucek, Sandra Demetiou, 
Diane Ruffing, Sandi Tait, and Esther Shaw. 
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